At a Glance
| Detail | Parambil | Skribe |
|---|---|---|
| Category | eDiscovery | eDiscovery |
| Total raised | $8M | $9M |
| Rounds tracked | 2 | 2 |
| Latest round | Seed, $6M · Jan 2026 | Seed, $5.5M · Mar 2026 |
| Last valuation | Not disclosed | Not disclosed |
| Lead investors | Bling Capital, Daybreak Ventures | Golden Section |
| Built for | Mid-size firms, Boutiques | Large firms, Mid-size firms |
| Headquarters | United States | United States |
Funding, Side by Side
Parambil rounds
- Jan 2026Seed$6M
- Jan 2025Seed$2M
Skribe rounds
- Mar 2026Seed$5.5M
- May 2024Seed$3.5M
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Parambil or Skribe?
- Skribe has raised $9M in disclosed funding, compared with $8M for Parambil.
- Do Parambil and Skribe share investors?
- No. None of the investors we track have backed both companies.
- What is Parambil best for?
- Parambil is AI medical record review software for mass tort and complex litigation.
- What is Skribe best for?
- Skribe is a digital reporting platform that captures depositions with secure video and human-verified transcripts.
Source: Legal Tech Circle funding data, from public announcements. Updated November 10, 2026.